tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TARA Stock Latest News

Protara Therapeutics, Inc. (TARA) Q3 Earnings Cheat Sheet
Pre-EarningsProtara Therapeutics, Inc. (TARA) Q3 Earnings Cheat Sheet
12d ago
TARA
Protara Therapeutics granted FDA Fast Track designation for IV Choline Chloride
PremiumThe Fly
Protara Therapeutics granted FDA Fast Track designation for IV Choline Chloride
20d ago
TARA
Protara Therapeutics completes first cohort in Phase 2 trial of TARA-002
PremiumThe Fly
Protara Therapeutics completes first cohort in Phase 2 trial of TARA-002
2M ago
TARA
Protara Therapeutics announce results from THRIVE-1 study
PremiumThe Fly
Protara Therapeutics announce results from THRIVE-1 study
2M ago
TARA
Protara Therapeutics price target lowered to $25 from $30 at Oppenheimer
PremiumThe Fly
Protara Therapeutics price target lowered to $25 from $30 at Oppenheimer
3M ago
TARA
Protara Therapeutics price target lowered to $20 from $22 at Guggenheim
PremiumThe FlyProtara Therapeutics price target lowered to $20 from $22 at Guggenheim
3M ago
TARA
Protara Therapeutics sees cash runway into 2026
Premium
The Fly
Protara Therapeutics sees cash runway into 2026
3M ago
TARA
Protara Therapeutics reports Q2 EPS (45c), consensus (80c)
Premium
The Fly
Protara Therapeutics reports Q2 EPS (45c), consensus (80c)
3M ago
TARA
TARA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
TARA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
TARA
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
PremiumStock Analysis & Ideas
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
6M ago
OPT
TARA
Protara Therapeutics files to sell 21.69M shares of common stock for holders
PremiumThe Fly
Protara Therapeutics files to sell 21.69M shares of common stock for holders
6M ago
TARA
Protara Therapeutics reports Q1 EPS (97c), consensus (92c)
PremiumThe Fly
Protara Therapeutics reports Q1 EPS (97c), consensus (92c)
6M ago
TARA
Protara Therapeutics price target raised to $30 from $26 at Oppenheimer
PremiumThe FlyProtara Therapeutics price target raised to $30 from $26 at Oppenheimer
7M ago
TARA
Protara Therapeutics Launches $45M Private Placement Drive
Premium
Company Announcements
Protara Therapeutics Launches $45M Private Placement Drive
7M ago
8K
TARA
Protara Therapeutics announces $45M private placement financing
Premium
The Fly
Protara Therapeutics announces $45M private placement financing
7M ago
TARA
Protara Therapeutics announces three-month data from TARA-002 program
PremiumThe Fly
Protara Therapeutics announces three-month data from TARA-002 program
7M ago
TARA
Protara announces alignment with FDA on path forward for IV Choline Chloride
PremiumThe Fly
Protara announces alignment with FDA on path forward for IV Choline Chloride
7M ago
TARA
Protara Therapeutics CMO Resigns, Interim Successor Named
PremiumCompany Announcements
Protara Therapeutics CMO Resigns, Interim Successor Named
8M ago
8K
TARA
Protara Therapeutics expects cash to fud operations into 2Q25
PremiumThe Fly
Protara Therapeutics expects cash to fud operations into 2Q25
8M ago
TARA
Protara Therapeutics reports Q4 EPS (90c), consensus (92c)
PremiumThe FlyProtara Therapeutics reports Q4 EPS (90c), consensus (92c)
8M ago
TARA
Is TARA a Buy, Before Earnings?
Premium
Pre-Earnings
Is TARA a Buy, Before Earnings?
8M ago
TARA
Protara announces additional results from Phase 1a dose-escalation of TARA-002
Premium
The Fly
Protara announces additional results from Phase 1a dose-escalation of TARA-002
12M ago
TARA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >